Please login to the form below

Not currently logged in


This page shows the latest immunotherapies news and features for those working in and with pharma, biotech and healthcare.

BMS defends Celgene buyout ahead of shareholder vote

BMS defends Celgene buyout ahead of shareholder vote

ahead. Another high profile BMS investor, Brad Loncar’s Loncar Cancer Immunotherapy ETF, also made its opposition to the deal clear earlier this month.

Latest news

More from news
Approximately 79 fully matching, plus 393 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....